Exhibit 5.1

                         L. STEPHEN ALBRIGHT LETTERHEAD

                                 January 6, 2005


ENHANCE BIOTECH, INC.
712 Fifth Avenue, 19th Floor
New York, New York   10019

Re:   Enhance Biotech, Inc. ("Company" or "Registrant"), Registration of 234,172
      Shares on Form S-8 Registration Statement ("Registration Statement")

Gentlemen:

      My opinion has been requested in connection with the registration of Two
Hundred Thirty Four Thousand One Hundred Seventy Two (234,172) shares of common
stock of the Company (the "Shares") which are issuable by the Registrant
pursuant to the Company's plan to compensate advisors who assisted in its
acquisition of Ardent Pharmaceuticals, Inc. (the "Plan"). The Shares are being
registered on a Form S-8 Registration Statement to which this opinion is
appended as an exhibit to the Registration Statement. Pursuant to the Plan, the
Shares will be restricted as to transfer through February 10, 2005, thereafter
there will be no restrictions imposed on the transfer and sale of the Shares.

      I have examined such corporate records and other documents and made such
examination of law as we have deemed relevant. Based on and subject to the
above, it is my opinion that the Shares, when issued pursuant to terms of the
Plan, will be duly authorized, legally issued, fully paid and non-assessable.

      I am a member of the Bar of the State of California and do not express any
opinion herein concerning any law other than the law of the State of California,
the General Corporation Law of the State of Delaware and the federal law of the
United States.

      I hereby consent to the filing of this opinion as an exhibit to the
Registration Statement and to the use of our name under the heading "Exhibits"
in the Registration Statement.

                                                   Very truly yours,

                                                   L. STEPHEN ALBRIGHT